ResearcherPage View Count

Geo Map
Region#
AS - Asia13638
NA - North America9184
EU - Europe6324
AF - Africa1221
OC - Oceania482
HKU - The University of Hong Kong423
SA - South America30
UND - Undefined336
Total31638
Country#
US - United States9053
CN - China7120
GB - United Kingdom3032
SG - Singapore1679
KR - Republic of Korea1623
HK - Hong Kong1562
IE - Ireland1548
ZA - South Africa969
NL - Netherlands916
JP - Japan820
OTH - Others3316
Total31638
City#
Ashburn4400
Beijing3009
Singapore1650
Dublin1547
Johannesburg965
Central632
Amsterdam616
Busan600
London532
Tokyo524
Others17163
Total31638
Paired donor interchange to avoid ABO-incompatible living donor liver transplantation271
Survival analysis of high-intensity focused ultrasound therapy versus radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma73
Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas61
Post-transplant endothelial progenitor cell mobilization via CXCL10/CXCR3 signaling promotes liver tumor growth88
Effect of donor steatosis on liver biochemistry and significance of body mass index and alanine aminotransferase in predicting steatosis118
Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: A 20-year experience149
Can positron emission tomography with the dual tracers [ 11C]acetate and [ 18F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?173
The Hong Kong experience and challenges26
Post-rituximab Burkitt transformation of PTLD: Loss of CD20 expression accompanied by a switch in light-chain expression175
Improvising hepatic venous outflow and inferior vena cava reconstruction for combined heart and liver and sequential liver transplantations56
Bile duct anastomotic stricture after right lobe adult-to-adult living donor liver transplantation126
A decade of right liver adult-to-adult living donor liver transplantation: The recipient mid-term outcomes172
Feasibility of laparoscopic re-resection for patients with recurrent hepatocellular carcinoma50
Life made easy: Simplifying reconstruction for dual portal veins in adult right lobe live donor liver transplantation163
Surgical treatment of the primary and secondary tumors of the liver33
Hepatitis B vaccination and preemptive treatment of hepatitis B virus in liver transplantation144
Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: prognosis and outcomes210
Pre-transplant live liver donor evaluation and perioperative care. Protocol of Queen Mary Hospital, University of Hong Kong97
The effect of donor age on the outcome of Liver Transplant in patients with Hepatitis B Virus Infection50
Low-volume deceased donor liver transplantation alongside a strong living donor liver transplantation service60
Effects of the liver volume and donor steatosis on errors in the estimated standard liver volume148
Donor quality of life12
Survival outcomes on resection of hepatocellular carcinoma with postoperative complications - a propensity score-matched analysis65
Management of solitary recurrent HCC: Is re-resection justified for those with adverse prognostic factors?66
Rapid measurement of indocyanine green clearance by pulse spectrophotometry: a validation study in 70 patients with Child-pugh A liver function148
Recurrence determined 10-year survival of hepatocellular carcinoma after hepatectomy70
Prospective study on donor quality of life before and after right lobe adult-to-adult live donor liver transplantation115
New insights after the first 1000 liver transplantations at The University of Hong Kong81
Perpetuating proficiency in donor right hepatectomy for living donor liver transplantation62
Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors53
Living donor versus deceased donor liver transplantation for early unresectable hepatocellular carcinoma: same criteria, different outcome107
Resection technique for live-donor transplantation49
Monday blues of deceased-donor liver transplantation144
Risk of recurrent hepatocellular carcinoma in chronic hepatitis B patients after liver transplantation70
Activation of AMPK by Metformin Attenuates Marginal Graft Injury via Promoting Mitochondrial Biogenesis100
Adult Living Donor Right Hepatectomy and Recipient Operation73
Adult-to-adult living donor liver transplantation: Operative techniques to optimize the recipient's outcome55
Simultaneous implantation of bilateral liver grafts in living donor liver transplantation by fusion venoplasty48
Single-centre experience of liver transplantation for familial amyloidotic polyneuropathy of non-Val30Met variants in Chinese patients177
The right may not be always right: Biliary anatomy contraindicates right lobe live donor liver transplantation137
Technical considerations for radical resection of a primary leiomyosarcoma of the vena cava68
Defining an optimal surgical strategy for synchronous colorectal liver metastases: Staged versus simultaneous resection?73
Re-resection for metachronous primary hepatocellular carcinoma: is it justified?55
Fatal graft-versus-host disease after unrelated cadaveric liver transplantation due to donor/recipient human leucocyte antigen matching (Letter to the Editor)38
The role and limitation of living donor liver transplantation for hepatocellular carcinoma112
Liver transplantation14
Hepatitis B vaccination in patients receiving antiviral monotherapy after liver transplantation for chronic hepatitis B42
Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosis59
Liver stiffness and histological features in healthy persons, and patients with occult hepatitis B, chronic active hepatitis B, and hepatitis B-related cirrhosis.45
Excellent outcomes of hepatitis B core antibody positive donors with oral antiviral agent alone in liver transplantation78
Resection of solitary lymph node metastasis for hepatocellular carcinoma after hepatectomy.71
Long-term outcome of lamivudine mono-prophylaxis after liver transplantation in Hepatitis B patients80
Laparoscopic versus open liver resection for elderly patients with malignant liver tumors: A single-center experience64
Internal hernia of the small bowel after right-lobe live donor liver transplantation140
Overestimating the liver volume for subjects with low body weight117
Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: A single-center experience59
Outcome of laparoscopic versus open hepatectomy for colorectal liver metastases53
Comparison of cryptogenic and hepatitis B related hepatocellular carcinoma38
Comparable outcomes of hepatocellular carcinoma after deceased donor vs. living donor liver transplantation45
Hemolysis and methemoglobinemia due to hepatitis E virus infection in patient with G6PD deficiency147
Open portal vein embolization29
SMALL VOLUME DECEASED DONOR LIVER TRANSPLANTATION ALONGSIDE LIVING DONOR LIVER TRANSPLANTATION16
Improved anterior hepatic transection for isolated hepatocellular carcinoma in the caudate62
A case of laparoscopic hepatectomy for recurrent hepatocellular carcinoma188
Recipient body size does not matter in pediatric liver transplantation89
Indications and contraindication of liver resection32
The use of hepatitis B core antibody positive donors for liver transplantation does not lead to inferior survival44
Portal inflow and pressure changes in right liver living donor liver transplantation including the middle hepatic vein124
Toward current standards of donor right hepatectomy for adult-to-adult live donor liver transplantation through the experience of 200 cases179
Increased applicability of liver transplantation in Hong Kong117
Impact of antiviral therapy on the survival outcome of patients after hepatectomy for hepatitis B-related hepatocellular carcinoma126
Efficacy of post liver transplant hepatitis B booster vaccination in chronic hepatitis B recipients with prior immune response85
Samaritan donor interchange in living donor liver transplantation59
Effect of changing paradigm for management of hepatocellular carcinoma on the long-term survival of patients with hepatocellular carcinoma115
General principles of organ transplantation21
NLRP3 inflammasome exacerbated fatty graft injury through activation of telomere-independent RAP1/KC axis after LDLT38
Bioethics of living donor liver transplantation28
Media coverage of liver transplant events promotes donations from the deceased23
Surgical options for treatment of hepatocellular carcinoma15
De novo sarcoma of donor origin in a liver allograft determined by microsatellite analysis: A short report198
Recurrent hepatitis B infection after liver transplantation for hepatitis B related diseases in Asian population: long term results of a single centre154
Recovering the recovering liver graft54
Clinicopathological study of renal biopsies after liver transplantation41
Entecavir monotherapy is effective in viral suppression after liver transplantation for hepatitis B122
Prediction of hospital mortality after liver transplantation for acute liver failure111
Salvage Transplantation for Recurrent Hepatocellular Carcinoma within Milan Criteria: Is It Worthwhile?42
Bile duct anastomotic stricture after pediatric living donor liver transplantation194
Pancreaticoduodenectomy with vascular reconstruction for adenocarcinoma of the pancreas with borderline resectability64
Survival analysis of hepatic resection for breast cancer metastases in Chinese women71
Value of live donor liver transplantation experience in major hepatectomy for hepatocellular carcinoma109
High-intensity focused ultrasound for hepatocellular carcinoma: A single-center experience213
Prospective blinded study on INTRAOPEATIVE ICG retention test for major hepatectomy – A direct functional measurement of future liver remnant110
Survival analysis of patients with transplantable recurrent hepatocellular carcinoma: Implications for salvage liver transplant121
Simplifying Living donor liver transplantation99
Accurate Prediction of Milan Criteria: The Role of Dual Tracer 18F-FDG and 11C-Acetate PET-CT Scan.64
A retrospective study on risk factors associated with failed endoscopic treatment of biliary anastomotic stricture after right-lobe living donor liver transplantation with duct-to-duct anastomosis77
Survival outcomes of right-lobe living donor liver transplantation for patients with high model for end-stage liver disease scores42
Biliary complications in liver transplantation175
Split graft liver transplant for paediatric patients in Hong Kong122
Advantage of primary liver transplantation for hepatocellular carcinoma within up-to-7 criteria with microvascular invasion122
Association between glucose 6-phosphate dehydrogenase (G6PD) deficiency and fatal outcome of hepatitis E infection in middle-aged men (Letter to the Editor)117
Resection of hepatocellular carcinoma after combined treatment with transarterial chemoembolization and sorafenib: a case report and literature review44
Evaluation of 11C-Acetate and 18F-FDG PET Scan with contrast CT on pathological and prognosis prediction in HCC Patients before Liver Transplantation - a Single-Institute Experience78
Donor quality of life before and after adult-to-adult right liver live donor liver transplantation203
Excellent outcomes of severely steatotic grafts in liver transplantation54
Liver transplantation for hepatocellular carcinoma69
Impact of extent of surgical resection on the outcomes of hepatocellular carcinoma based on prognostic factors49
Bile duct anastomotic stricture after adult-to-adult right lobe living donor liver transplantation136
Risks factors associated with failed endoscopic treatment for biliary anastomotic stricture after right lobe living donor liver transplantation70
Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma178
NLRP3 inflammasome initiated liver graft injury through telomere-independent repressor activator protein1 (RAP1) / keratinocyte chemoattractant (KC) axis67
Long Term Survival Analysis of Hepatectomy for Neuroendocrine Tumour Liver Metastases78
Acute appendicitis presenting with distal duodenal obstruction127
Modulation of graft vascular inflow guided by flowmetry and manometry in liver transplantation134
Clinical experience in managing Post Transplant Lymphoproliferative Disease (PTLD) in paediatric patients after liver transplant134
Donor perspective of right lobe adult-to-adult live donor liver transplantation257
Late recurrence of hepatocellular carcinoma after liver transplantation178
Implications for management of Mycobacterium tuberculosis infection in adult-to-adult live donor liver transplantation147
Metformin attenuated steatotic graft injury via promoting mitochondrial biogenesis after liver transplantation33
High-intensity focused ultrasound ablation: An effective bridging therapy for hepatocellular carcinoma patients89
Late recurrence of HCC after liver transplantation165
Role of portal vein embolisation in hepatocellular carcinoma management and its effect on recurrence: an intention-to-treat analysis216
Historical perspective of living donor liver transplantation173
Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation154
Simultaneous implantation of bilateral liver grafts in living donor liver transplantation with fusion venoplasty43
Alleviating the burden of small for size graft in right liver living donor liver transplantation30
Does hepatitis B seroconversion affect survival outcome in patients with hepatitis B related hepatocellular carcinoma?48
Patients with preoperative hepatorenal syndrome (HRS) have comparable long-term outcomes after live-donor liver transplantation (LDLT)141
Simplifying hepatic venous outflow reconstruction in sequential living donor liver transplantation192
Hepatitis B vaccination in patients receiving oral antiviral therapy without hepatitis B immunoglobulin after liver transplant313
Child-Pugh Parameters and Platelet Count as an Alternative to ICG Test for Assessing Liver Function for Major Hepatectomy36
Increasing the recipient-benefit to donor-risk ratio by lowering the graft size requirement for Living Donor Liver Transplantation60
Outcomes of endo-radiological approach to management of bile leakage after right lobe living donor liver transplantation52
Post-transplant lymphoproliferative disorders in liver transplant recipients: a clinicopathological study54
Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion181
Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation101
Operative outcomes of adult-to-adult right lobe live donor liver transplantation: A comparative study with cadaveric whole-graft liver transplantation in a single center107
Liver Failure and Liver Transplantation17
Survival advantage of primary liver transplantation for resectable hepatocellular carcinoma with vascular invasion140
Technical note on ALPPS for a patient with advanced hepatocellular carcinoma associated with invasion of the inferior vena cava41
Recipient body size dose not matter in paediatric liver transplantation30
Pure Laparoscopic Versus Open Left Lateral Sectionectomy for Hepatocellular Carcinoma: A Single-Center Experience90
Pseudo pseudocyst after right lobe live door liver transplantation27
Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B127
Head-to-head comparison of the right and left liver graft in adult-to-adult live donor liver transplantation131
Acute phase circulating micoRNAs predict tumor recurrence and survivals of hepatocellular carcinoma patients after liver transplantation86
Liver transplantation – Hong Kong and Macau12
Retrohepatic vena cava deroofing in living donor liver transplantation for caudate hepatocellular carcinoma63
Operative outcomes of adult-to-adult right lobe live donor liver transplantation: a comparative study with cadaveric whole-graft liver transplantation in a single center136
Low Volume Deceased Donor Liver Transplantation Alongside Living Donor Liver Transplantation58
Does spontaneous tumor rupture always has an adverse prognostic impact on patients with resectable hepatocellular carcinoma?104
Remnant left liver size and recovery of living right liver donors53
Liver transplantation for fulminant hepatic failure: As early as necessary and as late as possible44
Live liver donor mortality [1]46
Validating graft and standard liver size predictions in right liver living donor liver transplantation88
Oral nucleoside/nucleotide analogs without hepatitis b immune globulin after liver transplantation for hepatitis b63
Validation of graft and standard liver size predictions in right liver living donor liver transplantation154
Introduction to Clinical Research20
Estimating liver weight of adults by body weight and gender199
Asian perspective of liver transplantation for hepatocellular carcinoma26
Current status of management of liver cancer22
Radiological prognosticators of hepatocellular carcinoma treated by hepatectomy47
Outcomes of central bisectionectomy for hepatocellular carcinoma62
Efficacy of a pre-S containing vaccine in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B196
Long term survival analysis of hepatic resection for breast cancer metastases40
Effect of side and size of graft on surgical outcomes of adult-to-adult live donor liver transplantation133
Histological outcome after liver transplantation for chronic hepatitis B using oral antiviral therapy alone without hepatitis B immune globulin68
Reply16
Single centre experience of liver transplantation for familial amyloidotic polyneuropathy of non-Val30Met variant in Chinese patient133
Hepatic resection for incidentaloma114
Inhibitor development after liver transplantation in congenital factor VII deficiency50
Inflammasome Exacerbated Fatty Graft Injury Through Activation of Telomere-Independent RAP1/KC Axis After LDLT37
Excellent outcomes of severely steatotic grafts in liver transplantation61
Head-to-head comparison of the right and left liver graft in adult-to-adult live donor liver transplantation141
Applicability of histidine-tryptophan-ketoglutarate solution in right lobe adult-to-adult live donor liver transplantation154
Impact of graft type on the survival outcome of salvage Liver Transplantation for recurrent Hepatocellular Carcinoma68
Retransplantation using living-donor right-liver grafts100
Long-term outcomes of entecavir monotherapy after liver transplantation for hepatitis B: 5 years data36
Interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation in patients with chronic hepatitis B infection103
Acute liver failure. Contemporary management: prevention, treatment, and patient management18
Start writing radomized controlled trial23
Bioethical basis of liver transplantation for hepatocellular carcinoma15
Evaluation of the seventh edition of the American Joint Committee on Cancer tumour-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: Implications for the development of a refined staging system71
Radiofrequency ablation versus transarterial chemoembolization for unresectable solitary hepatocellular carcinomas sized 5-8 cm85
Outcomes of Living Donor Transplantation: The Eastern Perspective42
Rapid onset Chilaiditi's sign on top of fulminant hepatic failure155
Working up donors for high-urgency and elective adult-to-adult live donor liver transplantation171
Effects of donor steatosis on liver biochemistry and significance of body mass index in predicting steatosis69
Safety of ALPPS procedure by the anterior approach for hepatocellular carcinoma73
Use of sorafenib in recurrent hepatocellular carcinoma (HCC) after liver transplantation95
A decade of right liver adult-to-adult living donor liver transplantation - the recipients mid-term outcomes86
Rapid measurement of indocyanine green retention by pulse spectrophotometry: A validation study in 70 patients with Child-Pugh A cirrhosis before hepatectomy for hepatocellular carcinoma75
Outcomes of hepatectomy for hepatocellular carcinoma with bile duct tumour thrombus68
AMP-activated protein kinase attenuates marginal liver graft injury via promoting mitochondrial biogenesis and respiratory function58
Current status of liver transplantation25
The effect of wide resection margin in patients with intrahepatic cholangiocarcinoma: A single-center experience61
Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil to lamivudine100
Emergency re-routing of anterior sector venous outfow for right lobe living donor liver transplantation including the middle hepatic vein46
Transplantation of a 2-year-old deceased-donor liver to a 61-year-old male recipient77
Clinical factors affecting rejection rates in liver transplantation68
Patients with Pre-Operative Hepatorenal Syndrome (HRS) Have Poorer Long-Term Survival Outcome after Living Donor Liver Transplantation (LDLT)48
Increasing the recipient-benefit to donor-risk ratio by lowering the graft size requirement for living donor liver transplantation36
Donor quality of life before and after adult-to-adult live donor liver transplantation107
Analysis of long-term survival after hepatectomy for isolated liver metastasis of gastrointestinal stromal tumour72
Liver transplantation for hepatocellular carcinoma: The Hong Kong experience139
Validating graft and standard liver size predictions in right liver living donor liver transplantation145
The effect of high intensity focused ultrasound therapy in patients with HCC smaller than 3 cm39
Management of recurrent hepatocellular carcinoma after liver transplant – a single center experience27
Increasing the recipient benefit/donor risk ratio by lowering the graft size requirement for living donor liver transplantation65
Living donor liver transplantation: the Asian perspective37
Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter53
MARS treatment for a patient presenting with acquired hepatic glutamine synthetase deficiency after orthotopic liver transplantation152
Liver transplantation for acute-on-chronic liver failure192
Acute pancreatitis induced by transarterial chemoembolization: a single-center experience of over 1500 cases150
Results of percutaneous transhepatic cholecystostomy for high surgical risk patients with acute cholecystitis136
Surgical wound infection350
Wait and transplant for stage 2 hepatocellular carcinoma with deceased-donor liver grafts54
Resurgence of biliary cast syndrome164
Case Report of Relay Liver Transplantation With Graft Infected With Hepatitis B Virus59
Identification of a novel TTR Gly67Glu mutant and the first case series of familial transthyretin amyloidosis in Hong Kong Chinese159
Reply to "Wait and transplant for stage 2 hepatocellular carcinoma with deceased-donor liver grafts: how long should we wait?" (Correspondence)37
Liver Resection for De Novo Hepatocellular Carcinoma Complicated by Pyogenic Liver Abscess: A Clinical Challenge73
11C-acetate and 18F-FDG dual tracer PET scan with contrast CT provide the most accurate histopathology prediction in HCC patients - a study of explant histopathology in the model of liver transplantation151
Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria181
Reply: Underestimated role of 18F-FDG PET for HCC evaluation and promise of 18F-FDG PET/MR imaging in this setting63
Minimalist approach to donor hepatectomy50
Can Dual Tracer 18F-FDG and 11C-Acetate PET Scan Predict Venous Permeation in Hepatocellular Carcinoma?58
Significance of hepatitis B virus genotype in liver transplantation for chronic hepatitis B116
Durability of small-for-size living donor allografts52
Living donor liver transplantation for hepatocellular carcinoma across Milan criteria153
Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine214
NLRP3 inflammasome induced liver graft injury through activation of telomere-independent RAP1/KC axis121
Functional outcome following low anterior resection with total mesorectal excision in the elderly147
Portal inflow and pressure changes in right liver living donor liver transplantation including middle hepatic vein166
Liver transplant for paediatric oncology patient13
Long-term follow up of Hepatitis B virus-specific immune response in liver transplant patient receiving third-generation hepatitis B vaccine146
Side and size of grafts on surgical outcomes of adult-to-adult live donor liver transplantation104
Salvage living donor liver transplantation for recurrent hepatocellular carcinoma: salvaging the unsalvageable?108
Principle of Organ Transplantation16
Evaluation of survival after Primary Liver Transplantation for Hepatocellular Carcinoma within UCSF criteria47
Hematopoietic chimerism in liver transplantation patients and hematopoietic stem/progenitor cells in adult human liver190
Outcomes of liver resection for hepatocellular carcinoma with obstructive jaundice70
Outcomes of side-to-side conversion hepaticojejunostomy for biliary anastomotic stricture after right-liver living donor liver transplantation72
Meckel's diverticulum in action85
Asia's first combined liver transplant and aortic valve replacement52
NLRP3 inflammasome induced graft injury regulated by telomere-independent repressor activator protein 1 (RAP1) / keratinocyte chemoattractant (KC) axis after LDLT36
Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma178
Flowmetry-based portal inflow manipulation for a small-for-size liver graft in a recipient with spontaneous splenorenal shunt114
Tailoring donor hepatectomy per segment 4 venous drainage in right lobe live donor liver transplantation120
Survival outcome of re-resection for recurrent liver metastases of colorectal cancer: A retrospective study59
Outcome of living donors34
Hepatic resection for incidentaloma174
Pure laparoscopic hepatectomy versus open hepatectomy for hepatocellular carcinoma in 110 patients with liver cirrhosis: a propensity analysis at a single center63
Scoring for organ allocation34
Timely liver transplantation is essential for the survival of paediatric patients with hepatopulmonary syndrome139
Current status of downstaging of hepatocellular carcinoma before liver transplantation27
A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma208
Rescue Living-donor Liver Transplantation for Liver Failure Following Hepatectomy for Hepatocellular Carcinoma54
Living donor versus deceased donor liver transplantation for small unresectable hepatocellular carcinoma: same criteria, different outcome139
Treatment strategy for recurrent hepatocellular carcinoma: salvage liver transplantation, repeated hepatic resection, or radiofrequency ablation87
Survival advantage of primary liver transplantation for resectable hepatocellular carcinoma with vascular invasion within up-to-7 criteria142
Combined major liver resection and radiofrequency ablation for multifocal hepatocellular carcinoma61
Liver Transplantation15
Splanchnic hemodynamics in liver regeneration after right liver living donor liver transplantation182
Surgical outcomes in hepatocellular carcinoma patients with portal vein tumor thrombosis55
NLRP3 inflammasome regulated by telomere-independent Repressor Activator Protein1(RAP1) induced graft injury after LDLT73
Treatment strategy to improve long-term survival for hepatocellular carcinoma smaller than 5 cm: Major hepatectomy vs minor hepatectomy62
Management of spontaneously ruptured hepatocellular carcinomas in the radiofrequency ablation era67
High intensity focused ultrasound as a bridging therapy for patient with HCC - A hype or hope?114
Short- and long-term impact of reoperation for complications after major hepatectomy for hepatocellular carcinoma54
Safety of duct-to-duct biliary reconstruction in right-lobe live-donor liver transplantation without biliary drainage122
Versatility and viability of hepatic venoplasty in live donor liver transplantation using the right lobe with the middle hepatic vein99
Pediatric liver transplantation in Hong Kong-a domain with scarce deceased donors205
Modified model for end stage liver disease score accurately predicts death or liver transplantation in acute flares of chronic hepatitis B141
Hepatopancreatoduodenectomy for advanced hepatobiliary malignancies: a single-center experience47
Risk factors and outcome of patients with pancreatic fistula after radical pancreaticoduodenectomy40
Strategies for widening liver donor pool180
The friendly incidental portal vein thrombus in liver transplantation49
Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinoma56
Donor quality of life before and after adult-to-adult live donor liver transplantation95
Lowered Immune Cell Function in Liver Recipients Recovered From Posttransplant Lymphoproliferative Disease Who Developed Graft Tolerance61
Recurrent pyogenic cholangitis77
Comparable short and long term outcomes in living donor and deceased donor liver transplantation for patients with ultra high MELD scores55
A detailed evaluation of cardiac function in cirrhotic patients and its alteration with or without liver transplantation111
Tolerance of high-intensity focused ultrasound ablation in patients with hepatocellular carcinoma57
Hepatic resection for living donor transplantation150
Head-to-head comparison of the right and left liver graft in adult-to-adult live donor liver transplantation153
High-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients awaiting liver transplantation75
Phase II study of an 'all-oral' regimen of capecitabine, idarubicin and cyclophosphamide for metastatic breast cancer - safety, efficacy and quality of life52
A decade of right liver adult-to-adult live donor liver transplantation: mid-term outcomes141
Comparisons of surgical outcomes and recurrence after liver transplantation in patients with Hepatitis B vs. Hepatitis C related hepatocellular carcinoma59
Value of live donor liver transplantation experience in major hepatectomy for hepatocellular carcinoma113
Lipid profiles of donors and recipients of liver transplant: like father like son46
Survival analysis of transarterial radioembolization with yttrium-90 for hepatocellular carcinoma patients with HBV infection63
Best method of biliary reconstruction12
Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: A protocol with early elimination of steroids and reduction of tacrolimus dosage118
Resection of T4 HCC with surrounding structures83
HCC recurrence after Liver Transplantation in Asia vs. Europe: which is the difference?68
Long-term biological consequences of donor right hepatectomy including the middle hepatic vein in adult-to-adult live donor liver transplantation142
Acute liver failure and liver transplant20
Iatrogenic Chilaiditi's syndrome141
AMP-activated protein kinase attenuated marginal liver graft injury via promoting mitochondrial biogenesis and respiratory function56
Comparison of Survival Outcomes between Right Posterior Sectionectomy and Right Hepatectomy for Hepatocellular Carcinoma in Cirrhotic Liver: A Single-Centre Experience92
Outcomes including liver histology after liver transplantation for chronic hepatitis B using oral antiviral therapy alone134
Oral nucleoside/nucleotide analogs without hepatitis B immune globulin after liver transplantation for hepatitis B - long term outcome71
Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis152
Safety of donor right hepatectomy without abdominal drainage: A prospective evaluation in 100 consecutive liver donors134
Organ Transplantation (Liver)13
Entecavir versus lamivudine prophylaxis without hepatitis B immune globulin after liver transplantation for chronic hepatitis B136
Safety of perioperative aspirin in hepatocellular carcinoma patients undergoing hepatectomy91
Comparable short- and long-term outcomes in living donor and deceased donor liver transplantations for patients with Model for End-stage Liver Disease scores ≥35 in a hepatitis-B endemic area66
Selection of patients of hepatocellular carcinoma beyond the Milan criteria for liver transplantation43
Retransplantation using living donor right liver graft127
Renal cell carcinoma with inferior vena caval tumour thrombus: surgical management and clinical outcomes at a low-volume centre63
Prevention of hepatitis B recurrence after liver transplantation30
Liver transplant for biliary atresia is associated with a worse outcome: myth or fact?61
Survival Analysis of Re-resection Versus Radiofrequency Ablation for Intrahepatic Recurrence After Hepatectomy for Hepatocellular Carcinoma227
General principles of organ transplantation15
Fairness of liver graft allocation under current HCC MELD score exception policy in Hong Kong144
Primary treatment for hepatocellular carcinoma within UCSF criteria: comparing outcomes of deceased and living donor liver transplantation146
Right liver adult-to-adult live donor liver transplantation in Hong Kong124
Recurrence of hepatocellular cancer after liver transplantation: The role of primary resection and salvage transplantation in East and West76
Wide resection margin improves survival in patients with early intrahepatic cholangiocarcinoma - a 22-year single center experience89
Resection of T4 hepatocellular carcinomas with adjacent structures, is it justified?63
Safety of donor right hepatectomy for live donor liver transplantation without abdominal drainage101
Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection or radiofrequency ablation?54
Feasibility of Laparoscopic Re-resection for Patients with Recurrent Hepatocellular Carcinoma56
Recurrent pyogenic cholangitis162
Alleviating the burden of small-for-size graft in right liver living donor liver transplantation through accumulation of experience194
11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan Criteria: surgeon's perspective114
Impact of donor age on right lobe living donor liver transplantation in a single centre108
Small-for-size liver graft and hepatocellular carcinoma recurrence21
Use of liver stiffness measurement for liver resection surgery: correlation with indocyanine green clearance testing and post-operative outcome58
Comparable surgical outcomes after downstaging of unresectable hepatocellular carcinoma - a propensity score analysis62
Outcome of right liver living donor liver transplantation21
Liver transplantation: a life-saving procedure following amatoxin mushroom poisoning62
Outcomes of living donor liver transplantation for patients with preoperative type 1 hepatorenal syndrome and acute hepatic decompensation174
Rare cause of jaundice in a post liver transplant patient81
Anterior approach for liver resections95
Inflammasome exacerbated fatty graft injury with accumulation of myeloid-derived suppressor cells after living donor liver transplantation38


TotJulAugSepOctNovDecJanFebMarAprMayJun
2017/20183679287278215509274553164161541212239246
2018/20196422746413209205585709426717437518964493
2019/20205468810877142327414409649646381268364181
2020/2021124932722335410253841814424156795300937148434
2021/2022357597183307159406242001359335117928
2022/20231100000000000
Ever31638